Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Planning for progress: A US regulatory approach to advancing the clinical development of gene therapies

17 May 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to Health Systems, Economic Evaluations, Quality of Life

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35659866
DOI: 10.1016/j.ymthe.2022.05.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Planning for progress: A US regulatory approach to advancing the clinical development of gene therapiesPMID 35659866Read ↗

Gene Therapy Progress and Prospects: Bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environmentSemantic proximity Read ↗

Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory GuidelinesSemantic proximity Read ↗

Gene therapies development: slow progress and promising prospectSemantic proximity Read ↗

Development and Clinical Translation of Approved Gene Therapy Products for Genetic DisordersSemantic proximity Read ↗

Challenges and Pathways in Regulating Next-Gen Biological TherapiesSemantic proximity Read ↗

The Next Phase of Human Gene-Therapy OversightSemantic proximity Read ↗

The era of gene therapy: From preclinical development to clinical applicationSemantic proximity Read ↗

Optimizing regulatory frameworks for gene therapies in rare diseases: Challenges and solutionsSemantic proximity Read ↗

Ensuring a future for gene therapy for rare diseasesSemantic proximity Read ↗

Gene Therapy - Current ProgressSemantic proximity Read ↗

The Bespoke Gene Therapy Consortium: facilitating development of AAV gene therapies for rare diseasesSemantic proximity Read ↗

Gene therapy enters the pharma market: the short story of a long journey.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.